Literature DB >> 17998247

KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy.

Helina Tadesse1, Julie Deschênes-Furry, Sophie Boisvenue, Jocelyn Côté.   

Abstract

KH-type splicing regulatory protein (KSRP) is closely related to chick zipcode-binding protein 2 and rat MARTA1, which are involved in neuronal transport and localization of beta-actin and microtubule-associated protein 2 mRNAs, respectively. KSRP is a multifunctional RNA-binding protein that has been implicated in transcriptional regulation, neuro-specific alternative splicing and mRNA decay. More specifically, KSRP is an essential factor for targeting AU-rich element-containing mRNAs to the exosome. We report here that KSRP is arginine methylated and interacts with the Tudor domain of SMN, the causative gene for spinal muscular atrophy (SMA), in a CARM1 methylation-dependent fashion. These two proteins colocalize in granule-like foci in the neurites of differentiating neuronal cells and the CARM1 methyltransferase is required for normal localization of KSRP in neuronal cells. Strikingly, this interaction is abrogated by naturally-occurring Tudor domain mutations found in human patients affected with severe Type I SMA, a strong indication of its functional significance to the etiology of the disease. We also report for the first time that Q136E and I116F Tudor mutations behave similarly to the previously characterized E134K mutation, and cause loss of Tudor interactions with several cellular methylated proteins. Finally, we show that KSRP is misregulated in the absence of SMN, and this correlated with increased mRNA stability of its mRNA target, p21(cip1/waf1), in spinal cord of mild SMA model mice. Our results suggest SMN can act as a molecular chaperone for methylated proteins involved in RNA metabolism and provide new insights into the pathophysiology of SMA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998247     DOI: 10.1093/hmg/ddm327

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly.

Authors:  Paul G Donlin-Asp; Claudia Fallini; Jazmin Campos; Ching-Chieh Chou; Megan E Merritt; Han C Phan; Gary J Bassell; Wilfried Rossoll
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

Review 3.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

Review 4.  SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease.

Authors:  Darrick K Li; Sarah Tisdale; Francesco Lotti; Livio Pellizzoni
Journal:  Semin Cell Dev Biol       Date:  2014-04-24       Impact factor: 7.727

Review 5.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

Review 6.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

7.  SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.

Authors:  Mohini Jangi; Christina Fleet; Patrick Cullen; Shipra V Gupta; Shila Mekhoubad; Eric Chiao; Norm Allaire; C Frank Bennett; Frank Rigo; Adrian R Krainer; Jessica A Hurt; John P Carulli; John F Staropoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 8.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

Review 9.  Spinal muscular atrophy: journeying from bench to bedside.

Authors:  Tomoyuki Awano; Jeong-Ki Kim; Umrao R Monani
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

10.  Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Sabrina Salani; Dario Ronchi; Francesca Saladino; Andreina Bordoni; Francesco Fortunato; Roberto Del Bo; Dimitra Papadimitriou; Federica Locatelli; Giorgia Menozzi; Sandra Strazzer; Nereo Bresolin; Giacomo P Comi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.